ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC
Clinical trial NCT04032847 · TERMINATED
Trial details
- NCT number
- NCT04032847
- Sponsor
- Achilles Therapeutics UK Limited
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2024-09-26
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.